Welcome to our dedicated page for BIO-key International news (Ticker: $BKYI), a resource for investors and traders seeking the latest updates and insights on BIO-key International stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BIO-key International's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BIO-key International's position in the market.
BIO-key, a provider of Identity and Access Management (IAM) and Identity-Bound Biometric (IBB) solutions, will participate in the 2024 Virtual Tech Conference Series on June 4-5, presented by Maxim Group and hosted by M-Vest. CEO Mike DePasquale will join a Fireside chat on June 4th from 9:00 to 9:30 a.m. ET. The conference will feature discussions on how emerging growth companies leverage new technologies like AI. Investors can engage with management and submit questions during the event. Maxim Group, a full-service investment bank, will facilitate the conference, focusing on technological impacts on business growth.
BIO-key International (Nasdaq: BKYI), a provider of identity and access management solutions, received a non-compliance notice from Nasdaq on May 22, 2024.
The company failed to timely file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024. This delay is attributed to the ongoing restatement of financial statements for various periods in 2023. The company also remains delinquent in filing its Form 10-K for the period ended December 31, 2023.
BIO-key has until June 17, 2024, to submit a compliance plan to Nasdaq. If accepted, an extension until October 14, 2024, may be granted to regain compliance. The company intends to file the delayed reports soon to meet Nasdaq's listing requirements.
BIO-key International (Nasdaq: BKYI), a provider of Identity and Access Management (IAM) solutions, announced plans to file audited 2023 results and report Q1 2024 results next week. The company will also hold an investor call. Details will be provided once confirmed. BIO-key engaged Bush & Associates CPA on April 23, 2024, as its new independent registered public accounting firm.
BIO-key International, Inc. (NASDAQ: BKYI) has won the Hot Company Multi-Factor Authentication award at the 12th Annual Global InfoSec Awards at #RSAC 2024. The company's IAM platform PortalGuard® offers innovative authentication solutions, including biometric options for maximum security.
